European Urology Study Shows Lilly (LLY) Phase III of Cialis and Tamsulosin Improves BPH
Go back to European Urology Study Shows Lilly (LLY) Phase III of Cialis and Tamsulosin Improves BPH| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1255.40 +11.00 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1244.40 | 52 Week High | $88.16 | |||
| Open | $1232.00 | 52 Week Low | $67.88 | |||
| Day High | $1271.22 | P/E | 290.60 | |||
| Day Low | $1230.00 | EPS | $4.32 | |||
| Volume | 2,505,585 | |||||

